These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Johnston CI, Clappison BH, Anderson WP, Yasujima M. Am J Cardiol; 1982 Apr 21; 49(6):1401-4. PubMed ID: 6122371 [Abstract] [Full Text] [Related]
5. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs. Abe Y, Miura K, Imanishi M, Yukimura T, Komori T, Okahara T, Yamamoto K. J Pharmacol Exp Ther; 1980 Jul 21; 214(1):166-70. PubMed ID: 6156237 [Abstract] [Full Text] [Related]
8. Contribution of renal prostaglandins to the natriuretic action of bradykinin in the dog. Blasingham MC, Nasjletti A. Am J Physiol; 1979 Sep 21; 237(3):F182-7. PubMed ID: 474758 [Abstract] [Full Text] [Related]
12. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system. Filep J, Rigter B, Földes-Filep E. J Cardiovasc Pharmacol; 1987 Aug 21; 10(2):222-7. PubMed ID: 2441174 [Abstract] [Full Text] [Related]
13. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O, Shimamoto K. Adv Exp Med Biol; 1989 Aug 21; 247A():39-48. PubMed ID: 2532450 [Abstract] [Full Text] [Related]
16. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats. Harris PJ, Munro JO. J Physiol; 1984 Jun 21; 351():491-500. PubMed ID: 6205144 [Abstract] [Full Text] [Related]
20. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Ura N, Carretero OA, Erdös EG. Kidney Int; 1987 Oct 21; 32(4):507-13. PubMed ID: 2828746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]